FDA Alerts
FDA Recall of Insulin Delivery Device
The FDA is recalling Roche's ACCU-CHEK FlexLink Plus infusion set, a tool used to deliver insulin to diabetic patients.
A Kinked Cannula
Roche Insulin Delivery Systems announced today that it is notifying its customers and healthcare professionals about the recall of the ACCU-CHEK FlexLink Plus infusion set.
The Warning is on the Label
The FDA is notifying the public that information on the cardiovascular risks (including heart attack) of the diabetes drug rosiglitazone has been added to the physician labeling and patient Medication Guide.